InvestSMART

BCAL Diagnostics Limited (ASX: BDX) - Announcements

- Current share price for BDX : $0.060

ASX company news and announcements for BCAL Diagnostics Limited (BDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BCAL Diagnostics Limited (BDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BCAL Diagnostics Limited (BDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BCAL Diagnostics Limited (BDX)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$22 Appendix 4C Revised 4 Feb 2022 3:57PM $0.110 $0.060 fallen by 45.45%
$22 Becoming a substantial holder 31 Jan 2022 4:45PM $0.105 $0.060 fallen by 42.86%
$22 Quarterly Activities/Appendix 4C Cash Flow Report 27 Jan 2022 8:24AM $0.098 $0.060 fallen by 38.78%
$22 Dr John Hurrell Appointed Chief Executive Officer 11 Jan 2022 8:21AM $0.130 $0.060 fallen by 53.85%
$22 Application for quotation of securities - BDX 29 Dec 2021 3:08PM $0.135 $0.060 fallen by 55.56%
$22 Change In Directors Interest Notice - Correction 13 Dec 2021 6:19PM $0.140 $0.060 fallen by 57.14%
$22 Directors Change of Interest Notice X 2 13 Dec 2021 9:04AM $0.130 $0.060 fallen by 53.85%
$22 Results of Meeting 23 Nov 2021 7:26PM $0.150 $0.060 fallen by 60%
$22 Results of Meeting 22 Nov 2021 5:43PM $0.155 $0.060 fallen by 61.29%
$22 AGM Presentation 22 Nov 2021 3:58PM $0.153 $0.060 fallen by 60.66%
$22 Addendum to Appendix 4C 8 Nov 2021 9:45AM $0.150 $0.060 fallen by 60%
$22 Strong Cohort 4 Testing Data Demonstrates Value of BCAL Test 3 Nov 2021 8:21AM $0.155 $0.060 fallen by 61.29%
$22 Quarterly Activities/Appendix 4C Cash Flow Report 28 Oct 2021 9:18AM $0.160 $0.060 fallen by 62.50%
$22 Ceasing to be a substantial holder 26 Oct 2021 4:52PM $0.160 $0.060 fallen by 62.50%
$22 letter to Shareholders AGM Notice 21 Oct 2021 2:13PM $0.165 $0.060 fallen by 63.64%
$22 Notice of Annual General Meeting/Proxy Form 21 Oct 2021 2:10PM $0.165 $0.060 fallen by 63.64%
$22 AGM Date and Closing Date for Director Nominations 4 Oct 2021 8:31AM $0.170 $0.060 fallen by 64.71%
$22 Appendix 4G and Corporate Governance Statement 28 Sep 2021 8:32AM $0.175 $0.060 fallen by 65.71%
$22 Annual Report to shareholders 28 Sep 2021 8:23AM $0.175 $0.060 fallen by 65.71%
$22 Change of Director's Interest Notice 13 Sep 2021 7:16PM $0.195 $0.060 fallen by 69.23%
$22 Change of Director's Interest Notice 7 Sep 2021 2:20PM $0.225 $0.060 fallen by 73.33%
$22 Australian Clinical Studies Launched 3 Sep 2021 9:42AM $0.195 $0.060 fallen by 69.23%
$22 Preliminary Final Report 31 Aug 2021 10:53AM $0.160 $0.060 fallen by 62.50%
$22 Market Update 17 Aug 2021 10:25AM $0.160 $0.060 fallen by 62.50%
$22 Becoming a substantial holder 22 Jul 2021 5:05PM $0.225 $0.060 fallen by 73.33%

251 - 275 of 292 results

Page 11 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.